Borrero-Garcia Luis D, Moró-Carrión Marilyn, Torres-Cintrón Carlos R, Centeno-Girona Hilmaris, Perez Victoria, Santos-Colón Taymaraliz, González-Pons María
Division of Clinical and Translational Cancer Research, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Puerto Rico Central Cancer Registry, San Juan, Puerto Rico.
Cancer Med. 2025 Apr;14(8):e70851. doi: 10.1002/cam4.70851.
Although the overall colorectal cancer (CRC) incidence has been steadily declining in the United States, a dramatic increase in the number of CRC cases among individuals younger than 50 years of age (early-onset CRC) has been observed. CRC is the second and first leading cause of cancer death in the United States and among Hispanic men and women living in Puerto Rico (PRH), respectively. We report CRC incidence rates from 2000 to 2021 among PRH and compare them to data in the Surveillance, Epidemiology, and End Results Program (SEER).
Data on colorectal adenocarcinomas diagnosed between January 1, 2000, and December 31, 2021, were obtained from the Puerto Rico Central Cancer Registry and SEER17, including race and ethnicity. Age-standardized incidence rates were calculated using the direct method. The Joinpoint Regression Program calculated temporal trends on CRC incidence rates based on age-adjusted Average Annual Percent Change (AAPC) estimates.
A total of 729,479 incident cases of CRC were analyzed. US Hispanics had the highest percentage of early-onset CRC (EOCRC) cases (17.0%) among the racial and ethnic groups studied. PRH had the highest age-standardized EOCRC incidence rate (12.18 per 100,000 persons) and the highest increase in EOCRC incidence temporal trends (AAPC = 2.68; 95% CI: 1.83 to 3.51).
A significantly higher increase in EOCRC incidence was observed among Hispanic populations. Future studies should disaggregate Hispanic subpopulations by considering the country of ancestral origin, which will help identify specific risk factors and exposures and aid in developing tailored prevention and risk stratification strategies to reduce EOCRC incidence.
尽管美国结直肠癌(CRC)的总体发病率一直在稳步下降,但50岁以下个体(早发性CRC)的CRC病例数却显著增加。CRC分别是美国和居住在波多黎各的西班牙裔男性和女性(PRH)中癌症死亡的第二和首要原因。我们报告了2000年至2021年PRH的CRC发病率,并将其与监测、流行病学和最终结果计划(SEER)中的数据进行比较。
从波多黎各中央癌症登记处和SEER17获得了2000年1月1日至2021年12月31日期间诊断的结直肠腺癌数据,包括种族和民族。使用直接法计算年龄标准化发病率。Joinpoint回归程序根据年龄调整后的年均百分比变化(AAPC)估计值计算CRC发病率的时间趋势。
共分析了729479例CRC发病病例。在美国研究的种族和民族群体中,西班牙裔的早发性CRC(EOCRC)病例百分比最高(17.0%)。PRH的年龄标准化EOCRC发病率最高(每10万人中12.18例),EOCRC发病率时间趋势的增幅也最大(AAPC = 2.68;95%CI:1.83至3.51)。
在西班牙裔人群中观察到EOCRC发病率显著更高的增长。未来的研究应通过考虑祖籍国来细分西班牙裔亚人群体,这将有助于识别特定的风险因素和暴露情况,并有助于制定针对性的预防和风险分层策略,以降低EOCRC发病率。